Developing advanced laser particles for faster analysis of biological samples
Multi-color laser particles for high-throughput pooled analysis
This study is working on a new way to use colorful laser tags to help scientists quickly and accurately analyze biological samples, which could lead to exciting discoveries in medicine and drug development.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11128328 on NIH RePORTER |
What this research studies
This research focuses on creating innovative optical barcoding technology using multi-color laser particles to enhance the analysis of biological samples. By tagging cells or microbeads with these unique identifiers, the project aims to significantly improve the speed and accuracy of high-throughput assays, such as flow cytometry and immunoassays. The methodology involves developing a range of semiconductor laser particles that can be used to analyze multiple parameters simultaneously, which could lead to breakthroughs in biological discovery and drug development.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals undergoing diagnostic testing or treatment for conditions that require high-throughput biological analysis.
Not a fit: Patients who do not require high-throughput analysis or those with conditions that are not addressed by the technologies being developed may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more cost-effective methods for analyzing biological samples, ultimately improving patient diagnostics and treatment options.
How similar studies have performed: Previous research has shown success with optical barcoding technologies, indicating a promising potential for this novel approach.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Yun, Seok-Hyun Andy — Massachusetts General Hospital
- Study coordinator: Yun, Seok-Hyun Andy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.